Pathophysiology of sickle cell disease
Since the discovery of sickle cell disease (SCD) in 1910, enormous strides have been made
in the elucidation of the pathogenesis of its protean complications, which has inspired recent …
in the elucidation of the pathogenesis of its protean complications, which has inspired recent …
Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
RP McEver - Cardiovascular research, 2015 - academic.oup.com
The selectins are transmembrane, Ca2+-dependent lectins that mediate leucocyte rolling on
vascular surfaces, the first adhesive step during inflammation and immune surveillance …
vascular surfaces, the first adhesive step during inflammation and immune surveillance …
[HTML][HTML] Crizanlizumab for the prevention of pain crises in sickle cell disease
KI Ataga, A Kutlar, J Kanter, D Liles… - … England Journal of …, 2017 - Mass Medical Soc
Background The up-regulation of P-selectin in endothelial cells and platelets contributes to
the cell–cell interactions that are involved in the pathogenesis of vaso-occlusion and sickle …
the cell–cell interactions that are involved in the pathogenesis of vaso-occlusion and sickle …
P-selectin promotes neutrophil extracellular trap formation in mice
Neutrophil extracellular traps (NETs) can be released in the vasculature. In addition to
trap** microbes, they promote inflammatory and thrombotic diseases. Considering that P …
trap** microbes, they promote inflammatory and thrombotic diseases. Considering that P …
Aptamers from cell-based selection for bioanalytical applications
W Tan, MJ Donovan, J Jiang - Chemical reviews, 2013 - ACS Publications
Nucleic acids are the foundation of life. Specific sequences translate certain genetic traits,
protein expression, and, ultimately, cellular function. Yet, nucleic acids not only store genetic …
protein expression, and, ultimately, cellular function. Yet, nucleic acids not only store genetic …
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
D Manwani, PS Frenette - Blood, The Journal of the American …, 2013 - ashpublications.org
Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell
disease. Symptomatic management and prevention of these events using the fetal …
disease. Symptomatic management and prevention of these events using the fetal …
Inflammation in sickle cell disease
The primary β-globin gene mutation that causes sickle cell disease (SCD) has significant
pathophysiological consequences that result in hemolytic events and the induction of the …
pathophysiological consequences that result in hemolytic events and the induction of the …
Therapeutic strategies for sickle cell disease: towards a multi-agent approach
For over 100 years, clinicians and scientists have been unravelling the consequences of the
A to T substitution in the β-globin gene that produces haemoglobin S, which leads to the …
A to T substitution in the β-globin gene that produces haemoglobin S, which leads to the …
Anemia: progress in molecular mechanisms and therapies
Anemia is a major source of morbidity and mortality worldwide. Here we review recent
insights into how red blood cells (RBCs) are produced, the pathogenic mechanisms …
insights into how red blood cells (RBCs) are produced, the pathogenic mechanisms …
Design of a multifunctional nanozyme for resolving the proinflammatory plaque microenvironment and attenuating atherosclerosis
H He, Q Han, S Wang, M Long, M Zhang, Y Li… - ACS …, 2023 - ACS Publications
Persistent inflammation within atherosclerotic plaques is a crucial factor contributing to
plaque vulnerability and rupture. It has become increasingly evident that the …
plaque vulnerability and rupture. It has become increasingly evident that the …